Barclays PLC restated their overweight rating on shares of Equifax, Inc. (NYSE:EFX) in a report issued on Thursday. The brokerage currently has a $115.00 target price on the credit services provider’s stock, down from their prior target price of $150.00.

Several other equities analysts have also recently issued reports on EFX. Argus initiated coverage on shares of Equifax in a research note on Tuesday, June 13th. They issued a buy rating and a $166.00 price objective on the stock. BidaskClub raised shares of Equifax from a hold rating to a buy rating in a research note on Saturday, June 17th. Zacks Investment Research cut shares of Equifax from a buy rating to a hold rating in a research note on Monday, July 17th. Morgan Stanley reissued an equal weight rating and issued a $144.00 price objective (up from $142.00) on shares of Equifax in a research note on Tuesday, July 18th. Finally, Deutsche Bank AG reissued a buy rating and issued a $160.00 price objective (up from $140.00) on shares of Equifax in a research note on Thursday, July 27th. One research analyst has rated the stock with a sell rating, five have given a hold rating and nine have assigned a buy rating to the company. Equifax presently has a consensus rating of Buy and a consensus target price of $142.20.

Shares of Equifax (NYSE:EFX) traded down 4.6437% during mid-day trading on Thursday, reaching $92.1714. 10,051,754 shares of the company were exchanged. The stock has a market capitalization of $11.09 billion, a P/E ratio of 19.5237 and a beta of 0.93. Equifax has a 12 month low of $89.59 and a 12 month high of $147.02. The stock has a 50 day moving average price of $137.80 and a 200-day moving average price of $137.30.

Equifax (NYSE:EFX) last announced its quarterly earnings data on Wednesday, July 26th. The credit services provider reported $1.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.57 by $0.03. The company had revenue of $856.70 million for the quarter, compared to analysts’ expectations of $860.48 million. Equifax had a net margin of 17.44% and a return on equity of 24.88%. Equifax’s revenue was up 5.6% compared to the same quarter last year. During the same period in the previous year, the company posted $1.43 EPS. Analysts predict that Equifax will post $6.06 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: “Equifax, Inc. (EFX) Receives “Overweight” Rating from Barclays PLC” was first reported by Daily Political and is owned by of Daily Political. If you are viewing this report on another website, it was copied illegally and republished in violation of United States and international copyright law. The correct version of this report can be viewed at https://www.dailypolitical.com/2017/09/15/equifax-inc-efx-receives-overweight-rating-from-barclays-plc.html.

The business also recently announced a quarterly dividend, which will be paid on Friday, September 15th. Shareholders of record on Friday, August 25th will be given a dividend of $0.39 per share. The ex-dividend date of this dividend is Wednesday, August 23rd. This represents a $1.56 annualized dividend and a dividend yield of 1.62%. Equifax’s payout ratio is currently 33.05%.

In related news, CFO John W. Gamble, Jr. sold 6,500 shares of the business’s stock in a transaction dated Tuesday, August 1st. The shares were sold at an average price of $145.60, for a total value of $946,400.00. Following the sale, the chief financial officer now directly owns 42,078 shares in the company, valued at approximately $6,126,556.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Rodolfo O. Ploder sold 1,719 shares of the business’s stock in a transaction dated Wednesday, August 2nd. The stock was sold at an average price of $145.70, for a total transaction of $250,458.30. Following the completion of the sale, the insider now owns 43,648 shares in the company, valued at $6,359,513.60. The disclosure for this sale can be found here. Insiders have sold a total of 12,219 shares of company stock worth $1,780,938 over the last 90 days. Insiders own 1.29% of the company’s stock.

Several institutional investors have recently added to or reduced their stakes in the stock. Burgundy Asset Management Ltd. boosted its position in shares of Equifax by 0.7% in the 2nd quarter. Burgundy Asset Management Ltd. now owns 1,683,442 shares of the credit services provider’s stock worth $231,339,000 after buying an additional 11,216 shares in the last quarter. Intl Fcstone Inc. purchased a new stake in shares of Equifax in the 2nd quarter worth about $1,438,000. Sentry Investment Management LLC boosted its position in shares of Equifax by 1.4% in the 2nd quarter. Sentry Investment Management LLC now owns 7,057 shares of the credit services provider’s stock worth $970,000 after buying an additional 96 shares in the last quarter. Toronto Dominion Bank boosted its position in shares of Equifax by 25.9% in the 2nd quarter. Toronto Dominion Bank now owns 40,718 shares of the credit services provider’s stock worth $5,594,000 after buying an additional 8,364 shares in the last quarter. Finally, Dynamic Technology Lab Private Ltd purchased a new stake in shares of Equifax in the 2nd quarter worth about $1,055,000. Institutional investors and hedge funds own 90.02% of the company’s stock.

Equifax Company Profile

Equifax Inc is a global provider of information solutions and human resources business process outsourcing services for businesses, governments and consumers. The Company operates in four segments: U.S. Information Solutions (USIS), International, Workforce Solutions and Global Consumer Solutions. Its products and services are based on databases of consumer and business information derived from various sources, including credit, financial assets, telecommunications and utility payments, employment, income, demographic and marketing data.

Analyst Recommendations for Equifax (NYSE:EFX)

Receive News & Ratings for Equifax Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equifax Inc. and related companies with MarketBeat.com's FREE daily email newsletter.